- Home
- BDTX vs VOR Comparison
BDTX vs VOR Comparison
Compare BDTX & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDTX
- VOR
- Stock Information
- Founded
- BDTX 2014
- VOR 2015
- Country
- BDTX United States
- VOR United States
- Employees
- BDTX N/A
- VOR N/A
- Industry
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- VOR Biotechnology: Pharmaceutical Preparations
- Sector
- BDTX Health Care
- VOR Health Care
- Exchange
- BDTX Nasdaq
- VOR Nasdaq
- Market Cap
- BDTX 181.4M
- VOR 207.1M
- IPO Year
- BDTX 2020
- VOR 2021
- Fundamental
- Price
- BDTX $3.80
- VOR $25.13
- Analyst Decision
- BDTX Strong Buy
- VOR Buy
- Analyst Count
- BDTX 5
- VOR 6
- Target Price
- BDTX $10.40
- VOR $84.00
- AVG Volume (30 Days)
- BDTX 904.0K
- VOR 458.2K
- Earning Date
- BDTX 11-05-2025
- VOR 11-07-2025
- Dividend Yield
- BDTX N/A
- VOR N/A
- EPS Growth
- BDTX N/A
- VOR N/A
- EPS
- BDTX 0.25
- VOR N/A
- Revenue
- BDTX $70,000,000.00
- VOR N/A
- Revenue This Year
- BDTX N/A
- VOR N/A
- Revenue Next Year
- BDTX N/A
- VOR N/A
- P/E Ratio
- BDTX $15.26
- VOR N/A
- Revenue Growth
- BDTX N/A
- VOR N/A
- 52 Week Low
- BDTX $1.20
- VOR $2.62
- 52 Week High
- BDTX $4.45
- VOR $65.80
- Technical
- Relative Strength Index (RSI)
- BDTX 49.08
- VOR 43.55
- Support Level
- BDTX $3.67
- VOR $23.12
- Resistance Level
- BDTX $4.08
- VOR $28.66
- Average True Range (ATR)
- BDTX 0.24
- VOR 2.22
- MACD
- BDTX -0.06
- VOR -1.29
- Stochastic Oscillator
- BDTX 10.26
- VOR 19.42
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.